Gender
Item
1. male and female subjects.
boolean
C0079399 (UMLS CUI [1])
Age
Item
2. age range: 21-80 years old.
boolean
C0001779 (UMLS CUI [1])
Body Weight
Item
3. weight less than 115 kg.
boolean
C0005910 (UMLS CUI [1])
Therapeutic procedure Coronary Artery Disease Stable | CVD | Lesion Coronary angiography | Myocardial Infarction | Stress Test Positive
Item
4. clinically defined coronary artery disease that is clinical stable and compensated with appropriate treatment. coronary disease (cvd) is defined by the presence of lesions on coronary angiography, history of myocardial infarction, or positive stress test.
boolean
C0087111 (UMLS CUI [1,1])
C1956346 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0007222 (UMLS CUI [2])
C0221198 (UMLS CUI [3,1])
C0085532 (UMLS CUI [3,2])
C0027051 (UMLS CUI [4])
C3494508 (UMLS CUI [5,1])
C1514241 (UMLS CUI [5,2])
Informed Consent | Protocol Compliance
Item
5. willingness to give written informed consent and willingness and ability to understand, to participate to and to comply with the study requirements.
boolean
C0021430 (UMLS CUI [1])
C0525058 (UMLS CUI [2])
Nut Hypersensitivity
Item
1. history of nut allergy.
boolean
C0577620 (UMLS CUI [1])
Pregnancy | Breast Feeding | Urine pregnancy test
Item
2. pregnant or lactating women. pregnancy will be excluded by urine pregnancy test.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0430056 (UMLS CUI [3])
Illness Major | End stage cancer | Kidney Failure | Liver Failure | Gastrointestinal Diseases Impairing Intestinal Absorption | Condition Study Subject Participation Status Inappropriate
Item
3. clinical history of other major illness including end-stage cancer, renal failure, hepatic failure, gastrointestinal disorders that may impair absorption, or other conditions that in the opinion of the principal investigator make a clinical study inappropriate.
boolean
C0221423 (UMLS CUI [1,1])
C0205164 (UMLS CUI [1,2])
C0741884 (UMLS CUI [2])
C0035078 (UMLS CUI [3])
C0085605 (UMLS CUI [4])
C0017178 (UMLS CUI [5,1])
C0221099 (UMLS CUI [5,2])
C0021826 (UMLS CUI [5,3])
C0348080 (UMLS CUI [6,1])
C2348568 (UMLS CUI [6,2])
C1548788 (UMLS CUI [6,3])
Investigational New Drugs
Item
4. treatment with an investigational new drug within the last 30 days.
boolean
C0013230 (UMLS CUI [1])
Mental disorder Interferes with Comprehension Study Protocol | Condition Interferes with Comprehension Study Protocol
Item
5. history of a psychological illness or condition such as to interfere with the subject's ability to understand the requirements of the study.
boolean
C0004936 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0162340 (UMLS CUI [1,3])
C2348563 (UMLS CUI [1,4])
C0348080 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0162340 (UMLS CUI [2,3])
C2348563 (UMLS CUI [2,4])
Protocol Compliance Unwilling | Avoidance Nuts | Avoidance Vitamin E | Avoidance Vitamin C | Avoidance Beta Carotene | Avoidance Lipoic Acid | Avoidance Dietary Supplements | Avoidance Herbal supplement
Item
6. unwillingness to comply with the requirements of study including refraining from consumption of nuts and refraining from use of vitamin e, vitamin c, and beta carotene, lipoic acid, and/or other dietary or herbal supplements during the study.
boolean
C0525058 (UMLS CUI [1,1])
C0558080 (UMLS CUI [1,2])
C0870186 (UMLS CUI [2,1])
C0028723 (UMLS CUI [2,2])
C0870186 (UMLS CUI [3,1])
C0042874 (UMLS CUI [3,2])
C0870186 (UMLS CUI [4,1])
C0003968 (UMLS CUI [4,2])
C0870186 (UMLS CUI [5,1])
C0053396 (UMLS CUI [5,2])
C0870186 (UMLS CUI [6,1])
C0023791 (UMLS CUI [6,2])
C0870186 (UMLS CUI [7,1])
C0242295 (UMLS CUI [7,2])
C0870186 (UMLS CUI [8,1])
C1504473 (UMLS CUI [8,2])